Skip to main content

Table 4 Mean (95% CI) total costs per patient for 6 months prior to baseline and months 1–12

From: Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France

Cost; € (95% CI) 6 months prior to baseline (n=262) Months 1–12 (n=183)
Total costs 3726 (2876, 4575) 5237 (3949, 6526)
Total direct costs* 361 (327, 394) 563 (503, 623)
 Primary care visits**   99 (86, 112)
 Specialist visits**   45 (36, 54)
 Emergency room visits**   0.14 (-0.13, 0.41)
 Hospitalisations**   25 (-4, 55)
 Medication 203 (184, 222) 351 (314, 389)
Tests and procedures 157 (129, 186) 42 (20, 64)
 Total work productivity loss cost 3365 (2515, 4216) 4674 (3385, 5964)
 Cost of absence from work 906 (360, 1452) 799 (232, 1366)
 Cost of reduced productivity at work 2460 (1860, 3060) 3875 (2854, 4897)
  1. * Total direct costs include only costs of tests and procedures and costs of GERD-related prescribed medications; ** This information was not collected in the 6-month period prior to baseline.